I rate Arm Holdings (ARM) a Buy with a $544 price target, implying 64% upside from $332 per share. The main growth drivers ...
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results